曲美他嗪联合运动康复治疗老年慢性心力衰竭的疗效分析

被引：20

作者：

吴依霖 ^{[1
]}

黄伟 ^{[2
]}

机构：

[1] 大理大学临床医学研究生学院

[2] 大理大学昆明附属医院老年病科

来源：

重庆医学 | 2016年 / 45卷 / 32期

关键词：

慢性心力衰竭; 曲美他嗪; 运动康复; 心率变异性; 老年人;

D O I：

暂无

中图分类号：

R541.6 [血液循环衰竭];

学科分类号：

100201 [内科学];

摘要：

目的探讨曲美他嗪联合运动康复对老年慢性心力衰竭患者的心率变异性(HRV)疗效影响。方法 81例老年慢性心力衰竭患者随机分为曲美他嗪组(27例)、运动康复组(27例)和曲美他嗪联合运动康复治疗组(27例)。曲美他嗪组予口服曲美他嗪20mg,3次/天,运动康复组根据个体心肺运动试验结果制订运动处方治疗,联合治疗组采用两者联合治疗。分析3组患者治疗前及治疗3、6个月的HRV、左室射血分数(LVEF)和6min步行距离(6MWD)。结果联合治疗组与运动康复组比较:HRV时域指标即24h内全部窦性心博QRS波间距离(RR)间期的标准差(SDNN)、24h内连续5min一段的正常RR间期平均值的标准差(SDANN)增加[组间差异分别为(30.42±8.45)ms、(31.70±6.74)ms,P<0.05];LVEF及6MWD指标增加(P<0.05)。联合治疗组与曲美他嗪组比较:SDANN增加[组间差异为(37.98±6.74)ms,P<0.05];LVEF及6MWD指标增加(P<0.05)。结论联合治疗可使老年慢性心力衰竭患者获得更多裨益。

引用

页码：4554 / 4558

页数：5

共 13 条

[1]

Relation of impaired inter-organ communication and parasympathetic activity in chronic heart failure and multiple organ dysfunction syndrome.[J].H. Schmidt;U. Lotze;A. Ghanem;S.D. Anker;S. Said;R. Braun-Dullaeus;G. Oltmanns;S. Rose;M. Buerke;U. Müller-Werdan;K. Werdan;M. Rauchhaus.Journal of Critical Care.2013,

[2]

Prognostic value of heart rate turbulence for risk assessment in patients with unstable angina and non-ST elevation myocardial infarction.[J].Patricia Harris;Phyllis Stein;Drew;Fung.Vascular Health and Risk Management.2013, defa

[3]

Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation-tentative prophylactic properties of vagus nerve stimulation on malignant arrhythmias in heart failure [J].

Brack, Kieran E. ;

Winter, James ;

Ng, G. Andre .

HEART FAILURE REVIEWS, 2013, 18 (04) :389-408

[4]

Heart Rate Variability in Risk Stratification of Cardiac Patients [J].

Huikuri, Heikki V. ;

Stein, Phyllis K. .

PROGRESS IN CARDIOVASCULAR DISEASES, 2013, 56 (02) :153-159

[5]

Exercise training slows down heart rate and improves deceleration and acceleration capacity in patients with heart failure [J].

Ricca-Mallada, Roberto ;

Migliaro, Eduardo R. ;

Piskorski, Jaroslaw ;

Guzik, Przemyslaw .

JOURNAL OF ELECTROCARDIOLOGY, 2012, 45 (03) :214-219

[6]

Additional Use of Trimetazidine in Patients With Chronic Heart Failure [J].

Zhang, Lei ;

Lu, Yizhou ;

Jiang, Hong ;

Zhang, Liming ;

Sun, Aijun ;

Zou, Yunzeng ;

Ge, Junbo .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (10) :913-922

[7]

Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: Results from an international multicentre retrospective cohort study.[J].Gabriele Fragasso;Giuseppe Rosano;Sang Hong Baek;Hamayak Sisakian;Pericle Di Napoli;Luca Alberti;Giliola Calori;Seok-Min Kang;Laura Sahakyan;Armen Sanosyan;Cristiana Vitale;Giuseppe Marazzi;Alberto Margonato;Romualdo Belardinelli.International Journal of Cardiology.2012,

[8]

Improvements in heart rate variability with exercise therapy [J].

Routledge, Faye S. ;

Campbell, Tavis S. ;

McFetridge-Durdle, Judith A. ;

Bacon, Simon L. .

CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 (06) :303-312

[9]

Effect of exercise training on autonomic derangement and neurohumoral activation in chronic heart failure [J].

Gademan, Maaike G. J. ;

Swenne, Cees A. ;

Verwey, Harriette F. ;

Van Der Laarse, Arnoud ;

Maan, Arie C. ;

Van De Vooren, Hedde ;

Van Pelt, Johannes ;

Van Exel, Henk J. ;

Lucas, Caroline M. H. B. ;

Cleuren, Ger V. J. ;

Somer, Soeresh ;

Schalij, Martin J. ;

Van Der Wall, Ernst E. .

JOURNAL OF CARDIAC FAILURE, 2007, 13 (04) :294-303

[10]

Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) [J].

Piepoli, MF ;

Davos, C ;

Francis, DP ;

Coats, AJS ;

Belardinelli, R ;

Purcaro, A ;

Dubach, P ;

Myers, J ;

Giannuzzi, P ;

Temporelli, PL ;

Hambrecht, R ;

Linke, A ;

Kiilavuori, K ;

Leinonen, H ;

McKelvie, RS ;

Teo, KK ;

Volterrani, M ;

Giordano, A ;

Wielenga, RP ;

Baselier, MRP ;

Willenheimer, R ;

Rydberg, E ;

Adamopoulos, S ;

Dickestein, K ;

Gordon, A ;

Kostis, JB ;

Sellier, P ;

Toman, J .

BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7433) :189-192

← 1 2 →